Get A Grip! Global Study Shows Grip Strength Is a Simple And Powerful Predictor Of Death Reply

A large global study finds that grip strength is a simple, powerful, and broadly applicable test that can help predict the risk of death and cardiovascular disease. The new findings from the Prospective Urban-Rural Epidemiology (PURE) study were based on data from nearly 140,000 adults in 17 countries. The study participants had their grip strength measured with a handgrip dynamometer and were followed for roughly 4 years.

The results, published in the Lancet, show that grip strength is an even stronger predictor of death than systolic blood pressure…

Click here to read the full post on Forbes.

 

Advertisements

More Guideline Controversy: The Tricky Business Of Calculating Cardiovascular Risk Reply

Calculating cardiovascular risk has become a central and highly controversial component of cardiovascular guidelines. Now a study in the Annals of Internal Medicine finds that most of the commonly employed tools seriously overestimate the risk of people today.

Click here to read the full post on Forbes.

Healthy Habits Of Young Women Lead To Long-Term Health Benefits 1

It may seem obvious but a new study shows that young women with healthy habits are less likely as they age to get coronary heart disease or go on to develop cardiovascular risk factors like high blood pressure, high cholesterol, or diabetes.

Andrea Chomistek and colleagues analyzed data from more than 88,000 women participating in the Nurses Health Study II and who were between 27 and 44 years of age at the start of the study.

Click here to read the full post on Forbes.

 

670px-maraton_tel_aviv_-_beach_view

 

 

Beyond Kickbacks: More Questions About Unnecessary Cardiovascular Tests Reply

On the front page of the Wall Street Journal today is an important story about a fast-growing company accused of giving kickbacks to physicians who order the company’s tests measuring a wide variety of cardiovascular biomarker tests. But the article leaves one major question unasked: even if the company played fully by the rules, are most of the tests medically necessary?

In their story John Carreyrou and Tom McGinty write about a government investigation into Health Diagnostic Laboratory Inc. (HDL), which was started in 2008 and had $383 million in revenue last year. HDL sells tests that measure cardiovascular biomarkers and “bundles together up to 28 tests it performs on a vial of blood, receiving Medicare payments of $1,000 or more for some bundles.”

Click here to read the full post on Forbes.

 

Glucose Measurements Don’t Improve Cardiovascular Risk Assessment Reply

Although blood glucose and glycated hemoglobin (HbA1c) play a central role in diabetes, the value of these measurements to assess cardiovascular risk has been unclear. Now, in a paper published in JAMA, members of the Emerging Risk Factors Collaboration analyze data from nearly 300,000 people without known diabetes or cardiovascular disease who were enrolled in 73 prospective studies.

Click here to read the full post on Forbes.

 

 

More Rigorous Family History Improves CV Risk Assessment Reply

Although family history has long been recognized as an important cardiovascular risk factor, usual methods to assess risk have not incorporated the family history in a rigorous manner. A new study published in Annals of Internal Medicine finds that systematically collecting family history in a primary practice setting significantly increases the identification of high risk people.

Nadeem Quereshi and colleagues in the ADDFAM (Added Value of Family History in CVD Risk Assessment) Study Group studied 748 people without known CV disease who were seen in a family practice setting in the UK. In addition to a Framingham-based assessment of risk, half the patients were randomized to a systematic review of their family history.
Click to continue reading…